{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:13:18Z","timestamp":1791220398076,"version":"4.1.0"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/md.0b013e3181946a2c","type":"journal-article","created":{"date-parts":[[2009,1,19]],"date-time":"2009-01-19T03:13:29Z","timestamp":1232334809000},"page":"32-45","source":"Crossref","is-referenced-by-count":93,"title":["Androgen Dependence of Hirsutism, Acne, and Alopecia in Women"],"prefix":"10.1097","volume":"88","author":[{"given":"Sandra","family":"Karrer-Voegeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne J.","family":"Reymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Meuwly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf C.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulgencio","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210226","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2003-031780","article-title":"Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study.","volume":"89","author":"Ashraf Ganie","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-3-20210226","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/pgmj.2006.045377","article-title":"Acne: more than skin deep.","volume":"82","author":"Ayer","year":"2006","journal-title":"Postgrad Med J"},{"key":"R3-3-20210226","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-3-20210226","first-page":"347","article-title":"Idiopathic hirsutism.","volume":"21","author":"Azziz","year":"2000","journal-title":"Endocr Rev"},{"key":"R5-3-20210226","first-page":"810","article-title":"Nonclassic adrenal hyperplasia: current concepts.","volume":"78","author":"Azziz","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-3-20210226","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients.","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-3-20210226","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.","volume":"10","author":"Balen","year":"1995","journal-title":"Hum Reprod"},{"key":"R8-3-20210226","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2265.1983.tb02874.x","article-title":"Plasma and salivary androstenedione and dihydrotestosterone in women with hyperandrogenism.","volume":"18","author":"Baxendale","year":"1983","journal-title":"Clin Endocrinol"},{"key":"R9-3-20210226","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-3-20210226","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","article-title":"Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups.","volume":"83","author":"Chang","year":"2005","journal-title":"Fertil Steril"},{"key":"R12-3-20210226","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1210\/jc.2007-2429","article-title":"Insulin sensitizers for the treatment of hirsutism: a systematic review and meta-analyses of randomized controlled trials.","volume":"93","author":"Cosma","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-3-20210226","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-2007-970163","article-title":"Influence of body mass index on measured and calculated androgen parameters in adult women with hirsutism and PCOS.","volume":"115","author":"Cupisti","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R14-3-20210226","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","article-title":"Role of hormones in pilosebaceous unit development.","volume":"21","author":"Deplewski","year":"2000","journal-title":"Endocr Rev"},{"key":"R15-3-20210226","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2006-1054","article-title":"Oligo-anovulation with polycystic ovaries but not overt hyperandrogenism.","volume":"91","author":"Dewailly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-3-20210226","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2007-2053","article-title":"A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.","volume":"93","author":"Escobar-Morreale","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-3-20210226","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/09513590801911992","article-title":"Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women.","volume":"24","author":"Fanta","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"R18-3-20210226","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women.","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-3-20210226","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0190-9622(88)70241-8","article-title":"The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia.","volume":"19","author":"Futterweit","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"R20-3-20210226","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.2004.01973.x","article-title":"Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.","volume":"60","author":"Gambineri","year":"2004","journal-title":"Clin Endocrinol"},{"key":"R21-3-20210226","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1210\/jc.2006-0227","article-title":"Variants in the 5-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.","volume":"91","author":"Goodarzi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-3-20210226","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1055\/s-0028-1111126","article-title":"Behandlung des Hirsutismus mit Cyproterone Acetate.","volume":"94","author":"Hammerstein","year":"1969","journal-title":"Dtsch med Wochenschr"},{"key":"R23-3-20210226","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management.","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"R24-3-20210226","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1530\/acta.0.1090522","article-title":"Cyproterone acetate as initial treatment and maintenance therapy for hirsutism.","volume":"109","author":"Holdaway","year":"1985","journal-title":"Acta Endocrinol"},{"key":"R25-3-20210226","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1210\/jcem.87.6.8568","article-title":"Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.","volume":"87","author":"Ibanez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-3-20210226","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2265.2003.01792.x","article-title":"Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?","volume":"59","author":"Kaltsas","year":"2003","journal-title":"Clin Endocrinol"},{"key":"R27-3-20210226","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0022-4731(83)90225-X","article-title":"A comparison of androgen production and clearance in hirsute and obese women.","volume":"19","author":"Kirschner","year":"1983","journal-title":"J Steroid Biochem"},{"key":"R28-3-20210226","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0015-0282(03)00347-9","article-title":"The androgenic sex profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study.","volume":"79","author":"Korhonen","year":"2003","journal-title":"Fertil Steril"},{"key":"R29-3-20210226","first-page":"218","article-title":"Intracrinology and the skin.","volume":"54","author":"Labrie","year":"2000","journal-title":"Horm Res"},{"key":"R30-3-20210226","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2006.12.029","article-title":"A new classification of pattern hair loss that is universal for men and women: basic and specific (BASP) classification.","volume":"57","author":"Lee","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R31-3-20210226","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1210\/jcem-72-6-1242","article-title":"Clinical and biochemical parameters of androgen action in normal healthy caucasian versus Chinese subjects.","volume":"72","author":"Lookingbill","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-3-20210226","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archderm.1991.01680020078009","article-title":"Acne vulgaris in early adolescent boys. Correlations with pubertal maturation and age.","volume":"127","author":"Lucky","year":"1991","journal-title":"Arch Dermatol"},{"key":"R33-3-20210226","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0022-3476(97)70307-X","article-title":"Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study.","volume":"130","author":"Lucky","year":"1997","journal-title":"J Pediatr"},{"key":"R34-3-20210226","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2007-0282","article-title":"Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.","volume":"92","author":"Luque-Ramirez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-3-20210226","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000180291","article-title":"Further evidence for the usefulness of the salivary testosterone radioimmunoassay in the assessment of androgenicity in man in basal and stimulated conditions.","volume":"23","author":"Magrini","year":"1986","journal-title":"Horm Res"},{"key":"R36-3-20210226","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline.","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-3-20210226","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1210\/jcem-67-1-104","article-title":"Quantitating genetic and nongenetic factors influencing androgen production and clearance rates in men.","volume":"67","author":"Meikle","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"R38-3-20210226","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/0022-202X(93)90494-3","article-title":"The control of hair growth: an overview.","volume":"101","author":"Messenger","year":"1993","journal-title":"J Invest Dermatol"},{"key":"R39-3-20210226","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1471-0528.2003.02528.x","article-title":"LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant?","volume":"110","author":"Milsom","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"key":"R40-3-20210226","first-page":"89","article-title":"Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R41-3-20210226","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1210\/jc.2006-1085","article-title":"Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome.","volume":"91","author":"Murphy","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-3-20210226","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0015-0282(01)02963-6","article-title":"Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome.","volume":"77","author":"Nestler","year":"2002","journal-title":"Fertil Steril"},{"key":"R43-3-20210226","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaad.2004.04.008","article-title":"Evaluation and treatment of male and female pattern hair loss.","volume":"52","author":"Olsen","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R44-3-20210226","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1210\/jc.2002-021816","article-title":"Exon 6 and 2 peroxisome proliferator-activated receptor- polymorphisms in polycystic ovary syndrome.","volume":"88","author":"Orio","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R45-3-20210226","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/000456328902600611","article-title":"Salivary free testosterone in hirsutism.","volume":"26","author":"Osredkar","year":"1989","journal-title":"Ann Clin Biochem"},{"key":"R46-3-20210226","first-page":"46","article-title":"Evidence of excessive androgen secretion by both the ovary and the adrenal in patients with idiopathic hirsutism.","volume":"59","author":"Pugeat","year":"1982","journal-title":"Obstet Gynecol"},{"key":"R47-3-20210226","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archderm.1987.01660260079018","article-title":"The relationship of mild hirsutism or acne in women to androgens.","volume":"123","author":"Reingold","year":"1987","journal-title":"Arch Dermatol"},{"key":"R48-3-20210226","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0009-8981(90)90054-V","article-title":"Free testosterone levels in plasma and saliva as determined by a direct solid-phase radioimmunoassay: a critical evaluation.","volume":"191","author":"Rey","year":"1990","journal-title":"Clin Chim Acta"},{"key":"R49-3-20210226","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0039-128X(88)90152-3","article-title":"Interpretation of the discrepancy observed between plasma free and salivary testosterone levels in man.","volume":"52","author":"Rey","year":"1988","journal-title":"Steroids"},{"key":"R50-3-20210226","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1056\/NEJMcp033496","article-title":"Hirsutism.","volume":"353","author":"Rosenfield","year":"2005","journal-title":"N Engl J Med"},{"key":"R51-3-20210226","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement.","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R52-3-20210226","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"R53-3-20210226","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/jcem-64-5-1015","article-title":"Salivary testosterone in hirsutism: correlations with serum testosterone and the degree of hair growth.","volume":"64","author":"Ruutiainen","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-3-20210226","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0015-0282(00)01764-7","article-title":"Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.","volume":"75","author":"Sahin","year":"2001","journal-title":"Fertil Steril"},{"key":"R55-3-20210226","first-page":"2104","article-title":"Comparative rates of androgen production and metabolism in caucasian and Chinese subjects.","volume":"83","author":"Santner","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R56-3-20210226","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMcp072110","article-title":"Hair loss in women.","volume":"357","author":"Shapiro","year":"2007","journal-title":"N Engl J Med"},{"key":"R57-3-20210226","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2265.2000.00982.x","article-title":"Spironolactone as a single agent for long-term therapy of hirsute patients.","volume":"52","author":"Spritzer","year":"2000","journal-title":"Clin Endocrinol"},{"key":"R58-3-20210226","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jc.2007-2430","article-title":"Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials.","volume":"93","author":"Swiglo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R59-3-20210226","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/clinchem\/38.9.1819","article-title":"Low ratio of androstenedione to testosterone in plasma and saliva of hirsute women.","volume":"38","author":"Swinkels","year":"1992","journal-title":"Clin Chem"},{"key":"R60-3-20210226","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0015-0282(99)00633-0","article-title":"Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.","volume":"73","author":"Tartagni","year":"2000","journal-title":"Fertil Steril"},{"key":"R61-3-20210226","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/1523-1747.ep12317162","article-title":"Activity of the type 1 5-reductase exhibits regional differences in isolated sebaceous glands and whole skin.","volume":"105","author":"Thiboutot","year":"1995","journal-title":"J Invest Dermatol"},{"key":"R62-3-20210226","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2265.1993.tb02408.x","article-title":"Two different pathogenetic mechanisms may play a role in acne and in hirsutism.","volume":"39","author":"Toscano","year":"1993","journal-title":"Clin Endocrinol"},{"key":"R63-3-20210226","first-page":"CD001125","article-title":"Cyproterone acetate for hirsutism.","volume":"4","author":"Van der Spuy","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R64-3-20210226","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1210\/jcem-63-5-1204","article-title":"Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.","volume":"63","author":"Wajchenberg","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"R65-3-20210226","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2006-1191","article-title":"Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.","volume":"91","author":"Welt","year":"2006","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/md.0b013e3181946a2c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:31:00Z","timestamp":1786037460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-200901000-00003"}},"subtitle":["Retrospective Analysis of 228 Patients Investigated for Hyperandrogenism"],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181946a2c","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}